Cargando…
Neuroleptic malignant syndrome following reintroduction of an antipsychotic after overdose
Neuroleptic malignant syndrome (NMS) is a potentially lethal adverse drug reaction. We report a case of NMS potentially induced by dehydration in a female patient suffering from schizoaffective disorder. We discuss possible aetiologies and triggering factors alongside the existing literature.
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6078231/ https://www.ncbi.nlm.nih.gov/pubmed/30076161 http://dx.doi.org/10.1136/bcr-2017-223922 |
_version_ | 1783345055147229184 |
---|---|
author | Korchia, Théo Blackman, Graham Cermolacce, Michel Richieri, Raphaëlle |
author_facet | Korchia, Théo Blackman, Graham Cermolacce, Michel Richieri, Raphaëlle |
author_sort | Korchia, Théo |
collection | PubMed |
description | Neuroleptic malignant syndrome (NMS) is a potentially lethal adverse drug reaction. We report a case of NMS potentially induced by dehydration in a female patient suffering from schizoaffective disorder. We discuss possible aetiologies and triggering factors alongside the existing literature. |
format | Online Article Text |
id | pubmed-6078231 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | BMJ Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-60782312018-08-10 Neuroleptic malignant syndrome following reintroduction of an antipsychotic after overdose Korchia, Théo Blackman, Graham Cermolacce, Michel Richieri, Raphaëlle BMJ Case Rep Unexpected Outcome (Positive or Negative) Including Adverse Drug Reactions Neuroleptic malignant syndrome (NMS) is a potentially lethal adverse drug reaction. We report a case of NMS potentially induced by dehydration in a female patient suffering from schizoaffective disorder. We discuss possible aetiologies and triggering factors alongside the existing literature. BMJ Publishing Group 2018-08-03 /pmc/articles/PMC6078231/ /pubmed/30076161 http://dx.doi.org/10.1136/bcr-2017-223922 Text en © BMJ Publishing Group Limited 2018. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/. |
spellingShingle | Unexpected Outcome (Positive or Negative) Including Adverse Drug Reactions Korchia, Théo Blackman, Graham Cermolacce, Michel Richieri, Raphaëlle Neuroleptic malignant syndrome following reintroduction of an antipsychotic after overdose |
title | Neuroleptic malignant syndrome following reintroduction of an antipsychotic after overdose |
title_full | Neuroleptic malignant syndrome following reintroduction of an antipsychotic after overdose |
title_fullStr | Neuroleptic malignant syndrome following reintroduction of an antipsychotic after overdose |
title_full_unstemmed | Neuroleptic malignant syndrome following reintroduction of an antipsychotic after overdose |
title_short | Neuroleptic malignant syndrome following reintroduction of an antipsychotic after overdose |
title_sort | neuroleptic malignant syndrome following reintroduction of an antipsychotic after overdose |
topic | Unexpected Outcome (Positive or Negative) Including Adverse Drug Reactions |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6078231/ https://www.ncbi.nlm.nih.gov/pubmed/30076161 http://dx.doi.org/10.1136/bcr-2017-223922 |
work_keys_str_mv | AT korchiatheo neurolepticmalignantsyndromefollowingreintroductionofanantipsychoticafteroverdose AT blackmangraham neurolepticmalignantsyndromefollowingreintroductionofanantipsychoticafteroverdose AT cermolaccemichel neurolepticmalignantsyndromefollowingreintroductionofanantipsychoticafteroverdose AT richieriraphaelle neurolepticmalignantsyndromefollowingreintroductionofanantipsychoticafteroverdose |